These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33138378)

  • 21. Exploring three-dimensional matrix-assisted laser desorption/ionization imaging mass spectrometry data: three-dimensional spatial segmentation of mouse kidney.
    Trede D; Schiffler S; Becker M; Wirtz S; Steinhorst K; Strehlow J; Aichler M; Kobarg JH; Oetjen J; Dyatlov A; Heldmann S; Walch A; Thiele H; Maass P; Alexandrov T
    Anal Chem; 2012 Jul; 84(14):6079-87. PubMed ID: 22720760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Methoxy-indanone derivatives as potential probes for β-amyloid plaques in Alzheimer's disease.
    Nan DD; Gan CS; Wang CW; Qiao JP; Wang XM; Zhou JN
    Eur J Med Chem; 2016 Nov; 124():117-128. PubMed ID: 27565554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
    Klakotskaia D; Agca C; Richardson RA; Stopa EG; Schachtman TR; Agca Y
    PLoS One; 2018; 13(4):e0195469. PubMed ID: 29641600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging brain amyloid deposition using grating-based differential phase contrast tomography.
    Pinzer BR; Cacquevel M; Modregger P; McDonald SA; Bensadoun JC; Thuering T; Aebischer P; Stampanoni M
    Neuroimage; 2012 Jul; 61(4):1336-46. PubMed ID: 22450300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology.
    Praet J; Manyakov NV; Muchene L; Mai Z; Terzopoulos V; de Backer S; Torremans A; Guns PJ; Van De Casteele T; Bottelbergs A; Van Broeck B; Sijbers J; Smeets D; Shkedy Z; Bijnens L; Pemberton DJ; Schmidt ME; Van der Linden A; Verhoye M
    Alzheimers Res Ther; 2018 Jan; 10(1):1. PubMed ID: 29370870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
    Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
    J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nrf2 Suppresses Oxidative Stress and Inflammation in
    Uruno A; Matsumaru D; Ryoke R; Saito R; Kadoguchi S; Saigusa D; Saito T; Saido TC; Kawashima R; Yamamoto M
    Mol Cell Biol; 2020 Feb; 40(6):. PubMed ID: 31932477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered gamma-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation.
    Van Vickle GD; Esh CL; Kalback WM; Patton RL; Luehrs DC; Kokjohn TA; Fifield FG; Fraser PE; Westaway D; McLaurin J; Lopez J; Brune D; Newel AJ; Poston M; Beach TG; Roher AE
    Biochemistry; 2007 Sep; 46(36):10317-27. PubMed ID: 17705508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS.
    Kelley AR; Perry G; Bach SBH
    ACS Chem Neurosci; 2018 Apr; 9(4):708-714. PubMed ID: 29301075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide.
    Rábano A; Jiménez-Huete A; Acevedo B; Calero M; Ghiso J; Valdés I; Gavilondo J; Frangione B; Méndez E
    Curr Alzheimer Res; 2005 Oct; 2(4):409-17. PubMed ID: 16248846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardized processing of MALDI imaging raw data for enhancement of weak analyte signals in mouse models of gastric cancer and Alzheimer's disease.
    Schwartz M; Meyer B; Wirnitzer B; Hopf C
    Anal Bioanal Chem; 2015 Mar; 407(8):2255-64. PubMed ID: 25542565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring the three-dimensional distribution of endogenous species in the lungs by matrix-assisted laser desorption/ionization mass spectrometry imaging.
    Flinders B; Morrell J; Marshall PS; Ranshaw LE; Heeren RMA; Clench MR
    Rapid Commun Mass Spectrom; 2021 Jan; 35(1):e8957. PubMed ID: 32990347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. App
    Hamaguchi T; Tsutsui-Kimura I; Mimura M; Saito T; Saido TC; Tanaka KF
    Neurochem Int; 2019 Oct; 129():104470. PubMed ID: 31102607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atheroma-Specific Lipids in
    Cao J; Goossens P; Martin-Lorenzo M; Dewez F; Claes BSR; Biessen EAL; Heeren RMA; Balluff B
    J Am Soc Mass Spectrom; 2020 Sep; 31(9):1825-1832. PubMed ID: 32872786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.